ES2137153T3 - Uso de la prostaglandina e1 para curar la impotencia erectil masculina. - Google Patents

Uso de la prostaglandina e1 para curar la impotencia erectil masculina.

Info

Publication number
ES2137153T3
ES2137153T3 ES91108655T ES91108655T ES2137153T3 ES 2137153 T3 ES2137153 T3 ES 2137153T3 ES 91108655 T ES91108655 T ES 91108655T ES 91108655 T ES91108655 T ES 91108655T ES 2137153 T3 ES2137153 T3 ES 2137153T3
Authority
ES
Spain
Prior art keywords
prostaglandine
male erectile
erectile impotence
cure
cure male
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91108655T
Other languages
English (en)
Inventor
Alberto Reale
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11330110&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2137153(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2137153T3 publication Critical patent/ES2137153T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)

Abstract

UTILIZACION DE PROSTAGLANDINA E1 (ALPROSTADIL) EN LA PREPARACION DE COMPOSICIONES FARMACEUTICAS PARA EL TRATAMIENTO DE IMPOTENCIA MASCULINA, LLEVADA A CABO AL INTRODUCIR CANTIDADES TERAPEUTICAMENTE ACTIVAS DE LA MEDICACION EN LOS CUERPOS CAVERNOSOS DEL PENE.
ES91108655T 1990-05-31 1991-05-28 Uso de la prostaglandina e1 para curar la impotencia erectil masculina. Expired - Lifetime ES2137153T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT08620490A IT1247678B (it) 1990-05-31 1990-05-31 Metodo per la cura dell'impotenza erettiva maschile

Publications (1)

Publication Number Publication Date
ES2137153T3 true ES2137153T3 (es) 1999-12-16

Family

ID=11330110

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91108655T Expired - Lifetime ES2137153T3 (es) 1990-05-31 1991-05-28 Uso de la prostaglandina e1 para curar la impotencia erectil masculina.

Country Status (5)

Country Link
EP (1) EP0459377B1 (es)
AT (1) ATE183095T1 (es)
DE (1) DE69131517T2 (es)
ES (1) ES2137153T3 (es)
IT (1) IT1247678B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9203277A (pt) * 1992-08-21 1994-03-01 Cesar Roberto Dias Nahoum Utilizaccao de drogas eretogenicas e respectivas metodologias de aplicacao
US5773457A (en) * 1995-02-15 1998-06-30 Cesar Roberto Dias Nahoum Compositions
KR100422191B1 (ko) * 1994-08-05 2004-05-20 인파머 에스. 에이. 포스페티딜콜린과착물화된프로스타글란딘e1및/또는트록세루틴을함유하는발기불능국부치료용조성물
DE19728103A1 (de) * 1997-07-02 1999-01-07 Winfried Dr Med Heinicke Pharmazeutisches Präparat zur Behandlung erektiler Dysfunktion sowie Injektionshilfe zur Injektion des Präparats
US6399618B1 (en) 1997-07-09 2002-06-04 Cardiome Pharma Corp Compositions and methods for modulating sexual activity
US5942545A (en) * 1998-06-15 1999-08-24 Macrochem Corporation Composition and method for treating penile erectile dysfunction
JP2002518417A (ja) 1998-06-25 2002-06-25 ラヴィファム ラボラトリーズ インコーポレーテッド 勃起機能不全の治療装具及び方法
US7087240B1 (en) 1998-06-25 2006-08-08 Lavipharm Laboratories Inc. Device and method for the treatment of erectile dysfunction

Also Published As

Publication number Publication date
DE69131517T2 (de) 2000-01-13
IT9086204A1 (it) 1991-12-01
IT9086204A0 (it) 1990-05-31
IT1247678B (it) 1994-12-28
EP0459377B1 (en) 1999-08-11
EP0459377A2 (en) 1991-12-04
EP0459377A3 (en) 1992-09-16
DE69131517D1 (de) 1999-09-16
ATE183095T1 (de) 1999-08-15

Similar Documents

Publication Publication Date Title
AR025959A1 (es) DERIVADOS DE TER.-BUTIL-(7-METIL-IMIDAZO[1,2,a]PIRIDIN-3-IL)-AMINA, PROCEDIMIENTO PARA SU PREPARACION, MEDICAMENTOS QUE LOS CONTIENEN, SU USO PARA LAPREPARACION DE UN MEDICAMENTO PARA LA INHIBICION DE NO-SINTASA Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN
ES2069582T3 (es) Nucleosidos terapeuticos.
ES2113881T3 (es) Derivados y analogos de acido 2-desoxi-2,3-didehidro-n-acetil neuraminico y su utilizacion como agentes antivirales.
CO5680109A1 (es) Compuestos para el tratamiento de la disfuncion sexual femenina
ES2187578T3 (es) Compuestos biciclicos heterociclicos para el tratamiento de la impotencia.
ES2074124T5 (es) Composicion en forma de una espuma que contiene acido 5-aminosalicilico para administracion intra-rectal.
ES2147294T3 (es) Compuestos terapeuticos.
DE58906926D1 (de) Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung.
MX9304819A (es) Nuevos derivados de xantina y procedimiento para su preparacion.
ES2106794T3 (es) Utilizacion del inositol-trifosfato para el tratamiento de inflamaciones.
ES2177780T3 (es) Medicamentos para el tratamiento de enfermedades autoinmunes usando interferon tau.
AR022860A1 (es) Derivados de camptotecina que poseen actividad antitumoral
FR2609632B1 (fr) Nouvelle application therapeutique de la 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinon-6-one et les compositions pharmaceutiques destinees a cet usage
EA200400007A1 (ru) ФАРМАЦЕВТИЧЕСКИЙ СОСТАВ ДЛЯ ЭФФЕКТИВНОГО ВВЕДЕНИЯ АПОМОРФИНА, 6aR-(-)-N-ПРОПИЛ-НОРАПОМОРФИНА, ИХ ПРОИЗВОДНЫХ И ИХ ПРОЛЕКАРСТВ
ES2084579T3 (es) Uso de buspirona en la preparacion de una composicion farmaceutica para el tratamiento del abuso del alcohol.
ES2108969T3 (es) Utilizacion de analogos de didesoxinucleosidos en el tratamiento de infecciones virales.
TR200101719T2 (tr) Erkeklerde organik ereksiyona bağlı işlev bozukluğunun tedavisi için ilaç imalatında apomorfin kullanımı
ES2137153T3 (es) Uso de la prostaglandina e1 para curar la impotencia erectil masculina.
ES2066062T3 (es) Preparacion de liberacion sostenida para administracion al cerebro.
HUP9902094A2 (hu) PGE-1-tartalmú liofilizált liposzómák erekciós zavar kezelésében való alkalmazásra
ES2076190T3 (es) Uso de fluor que contiene derivados del acido piridona-carboxilico para la preparacion de un medicamento para el tratamiento de las infecciones causadas por hiv.
ES2078838A1 (es) Procedimiento para preparar una composicion a base de clozapina.
ES2078251T3 (es) Sistema para la distribucion regulada de agentes activos y proceso para su preparacion.
ES2072332T3 (es) Derivados de la dibenzo(1,5)dioxocin-5-ona, su uso en medicamentos y procedimiento para su fabricacion.
MX9302711A (es) Preparacion de base.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 459377

Country of ref document: ES